Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Tomsitz

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 16, 2021
Dirk Tomsitz, Tilo Biedermann, Knut Brockow
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 30, 2020
Skin manifestations reported in association with COVID-19 infectionDirk Tomsitz, Tilo Biedermann, Knut Brockow
Allergy|August 15, 2021
Sublingual immunotherapy reduces reaction threshold in three patients with wheat-dependent exercise-induced anaphylaxisDirk Tomsitz, Tilo Biedermann, Knut Brockow
Innere Medizin (Heidelberg, Germany)|August 8, 2024
[Side effects of Immune Checkpoint Inhibitors : Diagnostics and Management-an Update]Carolin Ertl, Dirk Tomsitz, Najib Ben Khaled
Journal of the American Academy of Dermatology|August 31, 2024
Clinical and pathological characterization of tebentafusp-associated skin toxicity: A cohort study with 33 patientsDirk Tomsitz, Katrin Kerl, Lars Einar French, et al.
Cancers|May 13, 2023
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint InhibitorsDirk Tomsitz, Theresa Ruf, Sarah Zierold, et al.
The Oncologist|September 10, 2025
Real-world management and outcomes of immune-related adverse events in German cancer care: A multicenter analysis using the SERIO registryCarolin Ertl, Dirk Tomsitz, Filippo Rizzo, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 25, 2025
CDK4/6 inhibitor in combination with aromatase inhibitor effective in metastatic hidradenocarcinomaValerie Glatzel, Dirk Tomsitz, Michaela Maurer, et al.
Clinical and Experimental Rheumatology|October 18, 2016
Digital ulcers score: a scoring system to assess digital ulcers in patients suffering from systemic sclerosisHannah Clara Ahrens, Elise Siegert, Dirk Tomsitz, et al.
European Journal of Cancer (Oxford, England : 1990)|December 21, 2024
Optimized monitoring for immune checkpoint inhibitor induced myocarditis using high-sensitivity troponin-TDirk Tomsitz, Ulrich Grabmaier, Judith Spiro, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 16, 2021
Dirk Tomsitz, Tilo Biedermann, Knut Brockow
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 30, 2020
Skin manifestations reported in association with COVID-19 infectionDirk Tomsitz, Tilo Biedermann, Knut Brockow
Allergy|August 15, 2021
Sublingual immunotherapy reduces reaction threshold in three patients with wheat-dependent exercise-induced anaphylaxisDirk Tomsitz, Tilo Biedermann, Knut Brockow
Innere Medizin (Heidelberg, Germany)|August 8, 2024
[Side effects of Immune Checkpoint Inhibitors : Diagnostics and Management-an Update]Carolin Ertl, Dirk Tomsitz, Najib Ben Khaled
Journal of the American Academy of Dermatology|August 31, 2024
Clinical and pathological characterization of tebentafusp-associated skin toxicity: A cohort study with 33 patientsDirk Tomsitz, Katrin Kerl, Lars Einar French, et al.
Cancers|May 13, 2023
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint InhibitorsDirk Tomsitz, Theresa Ruf, Sarah Zierold, et al.
The Oncologist|September 10, 2025
Real-world management and outcomes of immune-related adverse events in German cancer care: A multicenter analysis using the SERIO registryCarolin Ertl, Dirk Tomsitz, Filippo Rizzo, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 25, 2025
CDK4/6 inhibitor in combination with aromatase inhibitor effective in metastatic hidradenocarcinomaValerie Glatzel, Dirk Tomsitz, Michaela Maurer, et al.
Clinical and Experimental Rheumatology|October 18, 2016
Digital ulcers score: a scoring system to assess digital ulcers in patients suffering from systemic sclerosisHannah Clara Ahrens, Elise Siegert, Dirk Tomsitz, et al.
European Journal of Cancer (Oxford, England : 1990)|December 21, 2024
Optimized monitoring for immune checkpoint inhibitor induced myocarditis using high-sensitivity troponin-TDirk Tomsitz, Ulrich Grabmaier, Judith Spiro, et al.
Pageof 4